Reprogramming Gene Expression: Can Epigenome Editing Transform Disease Treatment?

Can diseases associated with abnormal gene expression be treated without permanently rewriting DNA? Programmable epigenome editing is opening new possibilities for precision therapeutics by enabling targeted gene activation, repression, and regulation without intentionally modifying underlying DNA sequences. In this episode of Frost & Sullivan’s Growth Podcast, we explore five questions shaping the future of programmable epigenome editing, examining how CRISPR-based technologies, zinc finger proteins, epigenetic effectors, and emerging delivery systems are advancing therapeutic research. The discussion explores potential applications across neuromuscular disorders, hepatitis B, cardiovascular and metabolic diseases, neurological conditions, and oncology. We also examine the development strategies of Epicrispr Biotechnologies, Modalis Therapeutics, Epitome Therapeutics, and Epigenic Therapeutics, highlighting how platform differentiation, therapeutic targeting, and clinical validation are influencing competition. Two emerging growth opportunities take center stage: compact epigenome editors for targeted therapeutic delivery and AI-enabled target and guide selection. Both are creating opportunities for technology licensing, research efficiency, strategic partnerships, and therapeutic platform expansion. 👉 Can programmable epigenome editing enable disease treatment without changing DNA sequences? 👉 Which therapeutic applications and technology platforms are best positioned for clinical translation? 👉 How can delivery innovation, AI-enabled discovery, and strategic partnerships accelerate commercialization? Designed for biotechnology companies, pharmaceutical developers, genomic medicine researchers, therapeutic platform providers, investors, and innovation leaders, this episode examines the technologies, clinical challenges, and strategic priorities shaping the future of programmable epigenome editing. Explore related research: https://www.frost.com | https://store.frost.com Connect with our team: [email protected]